Is medicine ready for AI? Doctors, computer scientists, and policymakers are cautiously optimistic
With the artificial intelligence conversation now mainstream, the 2023 MIT-MGB AI Cures conference saw attendance double from previous years.
With the artificial intelligence conversation now mainstream, the 2023 MIT-MGB AI Cures conference saw attendance double from previous years.
Citadel founder and CEO Ken Griffin visits MIT, discusses how technology will continue to transform trading and investing.
Experts convene to peek under the hood of AI-generated code, language, and images as well as its capabilities, limitations, and future impact.